Friday 6 November 2026 Export LUNG’s income statement to Excel — free account

Pulmonx Corporation

LUNG Healthcare Medical Devices

Pulmonx Corporation’s revenue for fiscal 2025 (year ended December 2025) was $90.5 million, up 8.01% from fiscal 2024.

Revenue: +6.20%
EPS: +42.8%
Free cash flow: +61.3%
Total debt: +1.57%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

2.56 0.00 0.00%

Follow LUNG

Alert me

Market cap: $111.5M
P/E: 0.0×
Fwd P/E: −3.1×
Dividend yield: —
F-score: 3/9
Altman Z: −4.84
Beneish M: −3.38
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		0.99	0.61	0.63	0.93
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(12.69)	(5.35)	(10.59)	(25.91)
P/B ratio Full definition →		1.66	1.18	1.41	2.41
Price to Tangible BV Full definition →		1.74	1.24	1.50	2.59
EV/Sales Full definition →		0.63	0.33	0.42	0.76
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(1.76)	(1.01)	(1.20)	(2.63)
EV/FCF Full definition →		(1.74)	(1.00)	(1.19)	(2.63)
Quick Ratio Full definition →		4.09	3.84	3.35	3.13
Current Ratio Full definition →		5.07	4.91	4.32	4.05
Net Debt/EBITDA Full definition →		3.42	1.94	2.15	2.13
Debt/Assets Full definition →		28.61%	31.02%	32.62%	34.22%
Debt/Equity Full definition →		0.68	0.81	0.95	1.10
Asset Turnover Full definition →		0.62	0.65	0.67	0.71
Operating CF/Net income Full definition →		0.68	0.74	0.52	0.38
Capex/Depreciation Full definition →		(0.05)	(0.03)	0.00	(0.02)
Interest Coverage Full definition →		(12.86)	(13.27)	(7.44)	(6.07)
Research and Development Expense of Revenue Full definition →		20.28%	23.80%	22.12%	21.30%
Selling, General and Administrative Expense of Revenue Full definition →		101.16%	117.07%	95.65%	87.69%
Intangible Assets out of Total Assets Full definition →		0.02	0.02	0.02	0.02
Share Based Compensation of Revenue Full definition →		18.77%	20.09%	16.25%	15.81%
Graham Net Nets Full definition →		0.29	0.34	0.23	0.10
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(60.18%)	(100.78%)	(89.23%)	(53.11%)
Free Cash Flow Yield Full definition →		(36.51%)	(54.42%)	(55.55%)	(31.05%)
Revenue per Share Full definition →		0.56	0.49	0.54	0.53
Operating CF per Share Full definition →		(0.17)	(0.24)	(0.12)	(0.07)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.17)	(0.24)	(0.12)	(0.07)
Cash per Share Full definition →		1.72	1.48	1.32	1.23
Shareholders Equity per Share Full definition →		1.33	1.09	0.92	0.79
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.33	1.09	0.92	0.79
Free Cash Flow Full definition →		(7.10)	(10.11)	(5.21)	(3.19)
Working Capital Full definition →		81.63	73.84	67.73	63.32
Capital Expenditures Full definition →		(0.01)	(0.01)	0.00	(0.01)
Net Current Asset Value Full definition →		26.51	18.54	12.60	8.05
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		12.60	12.40	14.08	12.91
Average Payables Full definition →		3.87	3.88	5.62	5.47
Average Inventory Full definition →		16.38	16.56	16.28	15.84
Average Assets Full definition →		146.07	135.35	130.96	124.25
Average Common Equity Full definition →		69.96	61.71	54.14	47.12

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly